AFFITOPE® PD01A

BIOLOGICAL3 trials

Sponsors

Affiris AG

Conditions

Parkinson's Disease

Phase 1

Tolerability and Safety of Subcutaneous Administration of Two Doses of AFFITOPE® PD01A in Early Parkinson's Disease

CompletedNCT01568099

Affiris AGParkinson's Disease

Start: 2012-02-29End: 2014-05-31Updated: 2015-08-17

Follow-up Study to Assess One Boost Immunization With AFFITOPE® PD01A With Regard to Safety and Clinical Activity

CompletedNCT02216188

Affiris AGParkinson's Disease

Start: 2014-08-31Updated: 2015-08-17

Follow-up Study to Assess a Second Boost Immunization With AFFITOPE® PD01A With Regard to Safety and Clinical Activity (AFF008AA)

CompletedNCT02618941

Affiris AGParkinson's Disease

Start: 2016-02-02End: 2017-02-28Updated: 2017-06-05